Health science and nutraceuticals player Sami Sabinsa Group on Wednesday said it is investing Rs 200 crore to build a manufacturing unit in Karnataka's Hassan district.
The new facility will be a Active Nutraceutical Ingredients (ANI) manufacturing unit having an annual capacity of 300 tonnes and will be functional by 2021, an official statement said.
The company statement cited a research saying that the worldwide nutraceutical market is expected to grow at 7.5 per cent per annum to touch USD 373 billion by 2025.
"The new unit when operational will play a pivotal role in boosting our exports further and help us to double our revenues," its founder and chairman Muhammed Majeed was quoted as saying.
The first phase of the facility will provide employment to around 400 people, he added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app